Since October 2018
Patent Attorney at df-mp
Nora Irene Hipp
Associate
Dr. rer. nat., M.Sc., B.Sc.
Dr. Nora Irene Hipp has been active in the field of intellectual property since 2015 and is authorized to represent clients before the German Patent and Trademark Office (GPTO), the German Federal Patent Court (GFPC), the German Federal Supreme Court (FSC; in appeals from the GFPC) as well as the European Union Intellectual Property Office (EUIPO). Since 2018, she complements df mp’s expertise in the Biotechnology and Pharmaceuticals Divisions.
+ 49 89 210 296 0
nora.hipp@df-mp.com
Dr. Nora Irene Hipp has been active in the field of intellectual property since 2015 and is authorized to represent clients before the German Patent and Trademark Office (GPTO), the German Federal Patent Court (GFPC), the German Federal Supreme Court (FSC; in appeals from the GFPC) as well as the European Union Intellectual Property Office (EUIPO). Since 2018, she complements df mp’s expertise in the Biotechnology and Pharmaceuticals Divisions.
practice areas.
Dr. Hipp has in-depth technical expertise inter alia in the fields of molecular biology, biochemistry, cell biology, immunology and epigenetics, particularly in relation to tumor diseases. As a member of df mp‘s Biotechnology and Pharmaceuticals Divisions, her activities focus on drafting and prosecuting patent applications, opposition proceedings and patent litigation.
admissions.
- German Patent Attorney
- European Trademark Attorney
- European Design Attorney
references and activities.
- Author and Co-Author of scientific publications in international journals in the field of tumor biology
- Various presentations in the field of tumor biology
curriculum vitae.
2015-2018
Patent Attorney candidate in the law firm König - Szynka - Tilmann - von Renesse, trainee at the German Patent and Trademark Office and the German Federal Patent Court
2009-2014
Doctorate and scientific employee at Ulm University, Institute of Physiological Chemistry, Ph.D. thesis on mechanisms of MYC-induced tumorigenesis in tumor entities of all three germ layers
2003-2008
Studies in Molecular Medicine at Ulm University Bachelor Thesis, Department of Experimental Neurology in the field of neuroregeneration of the CNS Master Thesis, Department of Pediatrics and Adolescent Medicine at the University Medical Centre Ulm dealing with pathomechanisms of neuroblastoma
publications.
- Hipp et al., “MYCN and survivincooperatively contribute to malignant transformation of fibroblasts.“Carcinogenesis (2014); 35(2):479-88.
- Sunami et al., “Hepatic activation of IKK/NFκB signaling induces liver fibrosis via macrophage-mediated chronic inflammation.” Hepatology (2012); 56(3):1117-28.
- Wahl et al., “Ewing’s sarcoma cells with CD57-associated increase of tumorigenicity and with neural crest-like differentiation capacity.“International Journal of Cancer (2010); 127(6):1295-307.
